NZ329403A - Treatment of B-cell lymphomas using a CD40 binding protein that inhibits the binding of CD40 to CD40L - Google Patents

Treatment of B-cell lymphomas using a CD40 binding protein that inhibits the binding of CD40 to CD40L

Info

Publication number
NZ329403A
NZ329403A NZ329403A NZ32940394A NZ329403A NZ 329403 A NZ329403 A NZ 329403A NZ 329403 A NZ329403 A NZ 329403A NZ 32940394 A NZ32940394 A NZ 32940394A NZ 329403 A NZ329403 A NZ 329403A
Authority
NZ
New Zealand
Prior art keywords
binding
cell lymphomas
cd40l
inhibits
treatment
Prior art date
Application number
NZ329403A
Inventor
Richard J Armitage
William C Fanslow
Dan L Longo
William J Murphy
Original Assignee
Nat Inst Of Health Nih
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Of Health Nih, Immunex Corp filed Critical Nat Inst Of Health Nih
Priority claimed from NZ278740A external-priority patent/NZ278740A/en
Publication of NZ329403A publication Critical patent/NZ329403A/en

Links

Abstract

The specification describes a method for treating b-cell lymphomas characterized by neoplastic cells that express CD40. The method involves administering a therapeutically effective amount of a CD40 binding protein in a pharmaceutically acceptable buffer. CD40 binding proteins include monoclonal antibodies to CD40, and CD40 ligand. CD40 binding proteins may also be used to prevent disease characterized by neoplastic cells that express CD40.
NZ329403A 1993-12-23 1994-12-21 Treatment of B-cell lymphomas using a CD40 binding protein that inhibits the binding of CD40 to CD40L NZ329403A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17266493A 1993-12-23 1993-12-23
NZ278740A NZ278740A (en) 1993-12-23 1994-12-21 Treating disease characterised by neoplastic cells expressing cd40 using a cd40 binding protein

Publications (1)

Publication Number Publication Date
NZ329403A true NZ329403A (en) 2000-09-29

Family

ID=26651511

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ329403A NZ329403A (en) 1993-12-23 1994-12-21 Treatment of B-cell lymphomas using a CD40 binding protein that inhibits the binding of CD40 to CD40L

Country Status (1)

Country Link
NZ (1) NZ329403A (en)

Similar Documents

Publication Publication Date Title
EP0751781A4 (en) Method of preventing or treating disease characterized by neoplastic cells expressing cd40
AU2001296547A1 (en) Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP0679093A1 (en) Methods of delivering agents to target cells.
IL206830A0 (en) Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
UA29494C2 (en) Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition
DE69709632D1 (en) HUMANIZED MONOCLONAL ANTI-CD40 ANTIBODIES AND FRAGMENTS TO INHIBIT B-CELL ACTIVATION
IL110672A0 (en) Therapeutic heterocycles
EP0765172A4 (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
EP1003494A4 (en) (d)-METHADONE, A NONOPIOID ANALGESIC
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
NZ329403A (en) Treatment of B-cell lymphomas using a CD40 binding protein that inhibits the binding of CD40 to CD40L
EP0791360A3 (en) Treatment of septic shock with anti-TNF antibodies
EP0904094A4 (en) Treatment of bone disorders with adrenomedullin
IL126158A0 (en) Method for treating substance abuse
WO2004019991A3 (en) Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma
GB2233559B (en) Antibodies for use in antilymphocyte antibody therapy
AU3633695A (en) Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
UA32551C2 (en) Method to keep fish in unfavourable conditions
UA8281A (en) Method for treatment of noncarrying of pregnancy at iso-leucocytic incompatibility

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired